首页> 美国卫生研究院文献>Clinical and Diagnostic Laboratory Immunology >Genetic and Antigenic Diversity of the Surface Protective Antigen Proteins of Erysipelothrix rhusiopathiae
【2h】

Genetic and Antigenic Diversity of the Surface Protective Antigen Proteins of Erysipelothrix rhusiopathiae

机译:丹毒丝菌表面保护抗原蛋白的遗传和抗原多样性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The surface protective antigen (Spa) protein of Erysipelothrix rhusiopathiae has been shown to be highly immunogenic and is a potential candidate for a new vaccine against erysipelas. In this study, we cloned and sequenced spa genes from all E. rhusiopathiae serovar reference strains as well as from a serovar 18 strain which was not classified as any species in the genus Erysipelothrix. Sequence analysis revealed that the Spa proteins could be classified into three molecular species, including SpaA, which was previously found in serovars 1a and 2, and the newly designated SpaB and SpaC proteins. The SpaA protein is produced by E. rhusiopathiae serovars 1a, 1b, 2, 5, 8, 9, 12, 15, 16, 17, and N, the SpaB protein is produced by E. rhusiopathiae serovars 4, 6, 11, 19, and 21, and the SpaC protein is produced only by serovar 18. The amino acid sequence similarity was high among members of each Spa type (96 to 99%) but low between different Spa types (∼60%). The greatest diversity in Spa proteins was found in the N-terminal half of the molecule (50 to 57% similarity), which was shown to be involved in immunoprotection. Coinciding with this, immunoblot analysis revealed that rabbit antisera specific to each Spa reacted strongly with the homologous Spa protein but weakly with heterologous Spa proteins. A mouse cross-protection study showed that the three recombinant Spa (rSpa) proteins elicited complete protection against challenge with homologous strains but that the level of protection against challenge with heterologous strains varied depending on the rSpa protein used for immunization. Our study is the first to demonstrate sequence and antigenic diversity in Spa proteins and to indicate that rSpaC may be the most promising antigen for use as a vaccine component because of its broad cross-protectiveness.
机译:已显示出红斑丹毒丝菌的表面保护性抗原(Spa)蛋白具有高度的免疫原性,是抗丹毒的新疫苗的潜在候选者。在这项研究中,我们从所有的大肠埃希氏菌血清参考菌株以及未在Erysipelothrix属中被归类为任何物种的18血清菌株中克隆并测序了spa基因。序列分析表明,Spa蛋白质可分为三个分子种类,包括先前在血清型1a和2中发现的SpaA以及新命名的SpaB和SpaC蛋白质。 SpaA蛋白由大肠埃希氏菌血清型1a,1b,2、5、8、9、12、15、16、17和N产生,SpaB蛋白由大肠埃希氏菌血清型4、6、11、19产生,和21,而SpaC蛋白仅由血清型18产生。在每种Spa类型的成员中,氨基酸序列相似性较高(96%至99%),而在不同Spa类型之间的氨基酸序列相似性较低(〜60%)。 Spa蛋白质的最大多样性出现在分子的N端一半(相似性为50%至57%),这表明它参与了免疫保护。与此同时,免疫印迹分析表明,每个Spa特有的兔抗血清与同源Spa蛋白反应强烈,而与异Spa蛋白反应较弱。一项小鼠交叉保护研究表明,三种重组Spa(rSpa)蛋白引发了针对同源菌株攻击的完全保护,但是针对异源菌株攻击的保护水平取决于用于免疫的rSpa蛋白。我们的研究首次证明Spa蛋白质中的序列和抗原多样性,并表明rSpaC可能是最有前途的抗原,因为它具有广泛的交叉保护作用,因此可以用作疫苗组分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号